This site is intended for healthcare professionals only

Issue:

Early View

Glycaemic control influences dementia risk in type 1 diabetes

Care of Older People – April 2019 Digest

Study examining the relationship between glycaemic control in type 1 diabetes and risk of dementia.

Lacy ME, Gilsanz P, Karter AJ et al (2018) Long-term glycemic control and dementia risk in type 1 diabetes. Diabetes Care 41: 2339–45

  • Despite considerable research into the impact of type 2 diabetes and glycaemic control on cognitive health in older people, less is known about the possible impact of hypoglycaemia and hyperglycaemia on dementia risk in type 1 diabetes.
  • Researchers in America followed a large group of patients aged 50 or older who had type 1 diabetes for a mean period of 6.3 years between 1996 and 2015. They obtained data on HbA1c measurements, comorbidities and dementia diagnoses from patients’ medical records to determine the long-term effects of glycaemic control on cognitive function.
  • During the study period, 155 out of the 3,433 participants (4.5%) received a diagnosis of Alzheimer’s disease, non-specific dementia or vascular dementia.
  • There was a 45% lower risk of any form of dementia in patients whose HbA1c measurements were 42–52 mmol/mol (6.0–6.9%) and 53–63 mmol/mol (7.0–7.9%) at least half of the time. In contrast, the risk of developing dementia was 79% higher in patients with HbA1c measurements ≥75 mmol/mol (≥9.0%) and 65% higher in those with HbA1c levels of 64–74 mmol/mol (8.0–8.9%) on ≥50% occasions. 
  • Cumulative exposure to hypoglycaemia (<42 mmol/mol; <6.0%) resulted in a non-significant increase in the likelihood of being diagnosed with dementia.
  • Prolonged exposure to higher HbA1c levels increased the risk of older people with type 1 diabetes developing dementia by at least twofold; whereas longer exposure to well-controlled glycaemic levels resulted in a 60% reduction in the risk of dementia.
  • This study demonstrated an association between chronic hyperglycaemia and decreased cognitive function, complementing the results of studies in children, adolescents and middle-aged people with type 1 diabetes, and in older adults with type 2 diabetes. 

Click here to access the article in full  
 

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.